Files
Download Full Text (598 KB)
Contents
- Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
- Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
- Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
- HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk
Publication Date
5-1-2017
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Olivarez, Patrick; Shpall, Elizabeth; Rezvani, Katy; Katz, Matthew H. G.; Parker, Nathan; Schadler, Keri; Ngo-Huang, An; Fogelman, David; William, William N., Jr.; Sepesi, Boris; Gibbons, Don L.; Receptors, Chimeric Antigen; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Clinical Trials as Topic; Preoperative Exercise; Chemotherapy, Adjuvant; Neoadjuvant Therapy; Immunotherapy; Adenocarcinoma; Pancreatic Neoplasms; Pancreatectomy; Carcinoma, Non-Small-Cell Lung; Genetic Testing; Genetic Counseling.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Munch, Joe; Tutt, Bryan; and Hale, Kathryn, "OncoLog, Volume 62, Number 05-06, May - June 2017" (2017). OncoLog MD Anderson's Report to Physicians (All issues). 280.
https://openworks.mdanderson.org/oncolog/280
Conditions Governing Access
Redacted
